Apollo Hospitals Enterprise Limited — PPTs, 12-08-2025: Investor Presentation

**Financial Highlights:**

Apollo Hospitals reported robust Q1 results with consolidated revenue surging 15% to ₹5,842.1 Cr. EBITDA grew 26% to ₹851.9 Cr, while net profit soared 42% to ₹432.8 Cr. Healthcare Services revenue increased 11%, Diagnostics 19%, and Apollo HealthCo 19%. HealthCo notably achieved a positive PAT for the quarter. Gross debt stood at ₹2,976.3 Cr, with net debt at ₹2,850.4 Cr.

**Strategic Initiatives & Growth Drivers:**

The company is aggressively expanding its bed capacity, planning to add 3,577 census beds over the next five years, backed by a capex of ₹760.3 Cr. Apollo HealthCo's Platform GMV grew 23% to ₹682.5 Cr, driven by strategic customer acquisition and significant growth in online pharmacy transactions (+42%) and transacting users (+36%). Diagnostics expanded with a new central reference lab and enhanced test menus.

**Business Developments:**

Apollo is executing hospital asset acquisitions and greenfield projects across key cities to bolster its network. A significant business development involves a composite scheme for Apollo HealthCo, proposing the demerger and amalgamation of its digital and pharmacy distribution businesses. This strategic move aims for a direct listing and Indian ownership, optimizing its omnichannel platform.

**Market Position & Competitive Advantage:**

Apollo solidified its standing as India's largest pan-India hospital chain and the leading omnichannel healthcare platform. Its integrated approach, combining advanced digital health services with an expansive network of pharmacies and diagnostic centers, provides a formidable competitive edge in delivering comprehensive last-mile care.

**Investor Implications:**

The strong financial performance, combined with aggressive capacity expansion and the strategic restructuring of the digital health division, indicates significant positive growth potential. The planned listing of Apollo HealthCo is set to unlock substantial shareholder value, positioning the company favorably for investors.